Tempest Therapeutics, Inc.
TPST
$6.87
$0.385.86%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 30.27M | 22.12M | 31.12M | 32.33M | 39.23M |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 642.00K | 811.00K | 272.00K | 585.00K | 700.00K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 564.00K | 625.00K | 152.00K | 586.00K | 433.00K |
Total Current Assets | 31.47M | 23.55M | 31.55M | 33.50M | 40.36M |
|
|||||
Total Current Assets | 31.47M | 23.55M | 31.55M | 33.50M | 40.36M |
Net Property, Plant & Equipment | 9.53M | 9.84M | 10.17M | 10.43M | 10.79M |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 485.00K | 448.00K | 448.00K | 448.00K | 448.00K |
Total Assets | 41.49M | 33.84M | 42.17M | 44.38M | 51.60M |
|
|||||
Total Accounts Payable | 2.45M | 1.70M | 1.36M | 1.05M | 845.00K |
Total Accrued Expenses | 4.55M | 2.94M | 3.62M | 2.32M | 3.33M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 7.22M | 9.33M | 9.58M | 7.32M | 5.24M |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | 14.22M | 13.97M | 14.56M | 10.69M | 9.41M |
|
|||||
Total Current Liabilities | 14.22M | 13.97M | 14.56M | 10.69M | 9.41M |
Long-Term Debt | -- | -- | 2.01M | 4.14M | 6.26M |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 8.14M | 8.41M | 8.66M | 8.92M | 9.16M |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 22.36M | 22.38M | 25.23M | 23.75M | 24.84M |
|
|||||
Common Stock & APIC | 226.23M | 204.75M | 199.68M | 193.80M | 192.03M |
Retained Earnings | -207.11M | -193.29M | -182.74M | -173.17M | -165.26M |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | 19.13M | 11.46M | 16.94M | 20.63M | 26.77M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 19.13M | 11.46M | 16.94M | 20.63M | 26.77M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 19.13M | 11.46M | 16.94M | 20.63M | 26.77M |
|